Cardarine (also known as GW-501516 and Endurobol) is a PPARδ receptor agonist that was developed by Ligand Pharmaceuticals and GSK for the treatment of metabolic and cardiovascular diseases. Unfortunately, it was abandoned after a controversial study in which rats developed cancer came out. Cardarine works by activating PPAR-Delta receptors, which in turn upregulate the expression […]Read More